Singapore IPO investors give Religare clean bill of health
Religare Health Trust priced its Singapore IPO just below the midpoint of its price range this week to raise S$511m ($417m), despite 140 investors placing orders for nearly three times the amount of shares on offer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts